Did you mean iodide i 10?
Displaying drugs 3326 - 3350 of 3712 in total
CYNK-101
CYNK-101 is an allogeneic human placental hematopoietic stem cell-derived natural killer (NK) cell therapy product that is genetically modified to express a variant of CD16 (CD16VP).
Investigational
AB-22
Investigational
Ongericimab
Ongericimab is under investigation in clinical trial NCT05325203 (A Study to Evaluate the Efficacy and Safety of JS002 in Patients With Heterozygous Familial Hypercholesterolemia (Hefh).).
Investigational
(4R)-limonene 1α,2α-epoxide
Experimental
Rexin G
Rexin-G is a tumor-targeted, injectable retroviral vector carrying a mutant form of the cyclin G1 gene. It is under development by Epeius Biotechnologies for the potential treatment of metastatic cancer. It is also being investigated for preventing SARSCOV-2 viral entry.
Investigational
Tegoprubart
Investigational
Tilavonemab
Investigational
TH-9402 free base
Investigational
Delolimogene mupadenorepvec
Investigational
Trimethyltetradecylammonium
Investigational
LSTA1
Investigational
Osemitamab
Investigational
Pulocimab
Pulocimab is under investigation in clinical trial NCT06341335 (A Study of Ak104/placebo Plus Ak109/placebo and Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma).
Investigational
Displaying drugs 3326 - 3350 of 3712 in total